Complete remission of a metastatic neuroendocrine tumor of the pancreas with capecitabine (Xeloda®) monotherapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer chemotherapy and pharmacology 2008-02, Vol.61 (2), p.347-348
Hauptverfasser:	Fürstenberger, Gregor, Schmid, Peter, Duquesne, Ans, Ammann, Maria, Senn, Hans-Jörg
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimetabolites, Antineoplastic - therapeutic use Antineoplastic agents Biological and medical sciences Cancer Research Capecitabine Chromogranin A - blood Deoxycytidine - analogs & derivatives Deoxycytidine - therapeutic use Fluorouracil - analogs & derivatives Fluorouracil - therapeutic use Humans Male Medical sciences Medicine Medicine & Public Health Middle Aged Neoplasm Metastasis Neuroendocrine Tumors - diagnostic imaging Neuroendocrine Tumors - drug therapy Oncology Pancreatic Neoplasms - diagnostic imaging Pancreatic Neoplasms - drug therapy Pharmacology. Drug treatments Pharmacology/Toxicology Short Communication Tomography, X-Ray Computed
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!